1. Home
  2. NKGNW

NKGNW

NKGen Biotech Inc. Warrants

Logo NKGen Biotech Inc. Warrants

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 03-11-2024 4:50pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
-
.
-
-
%

NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.

Founded: N/A Country:
United States
United States
Employees: 65 City: SANTA ANA
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: